Vanguard Group’s Zymergen Inc. Common Stock ZY Stock Holding History

Vanguard Group’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,436,119	Closed	-$6.77M	–	4613
2022 Q3	$6.77M	Buy	2,436,119 +555,992	+30%	+$1.35M	﹤0.01%	3153
2022 Q2	$2.31M	Sell	1,880,127 -808,297	-30%	-$1.36M	﹤0.01%	3744
2022 Q1	$7.77M	Sell	2,688,424 -1,201,647	-31%	-$5.1M	﹤0.01%	3282
2021 Q4	$26M	Buy	3,890,071 +2,148,127	+123%	+$20.9M	﹤0.01%	2696
2021 Q3	$22.9M	Buy	1,741,944 +31,422	+2%	+$667K	﹤0.01%	2787
2021 Q2	$68.4M	Buy	+1,710,522	New	+$67.5M	﹤0.01%	2203

Vanguard Group's ZY Position: Q4 2022 in Review

Vanguard Group sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 2,436,119 shares — an estimated $6.77M sold.

Vanguard Group first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $68.4M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Vanguard Group reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Vanguard Group sold 2,436,119 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $6.77M.
Vanguard Group first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Vanguard Group's Zymergen Inc. Common Stock position peaked at $68.4M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.